SPY759.36+0.30%QQQ691.44+0.48%BTC/USD71,025.39−0.48%DIA523.78+0.25%GLD355.76+0.25%TLT79.63−0.11%

Alvotech

ALVONASDAQ

Trade with Public

$4.67

-0.25-5.08%

Last update: Nov 12, 9:28 AM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Compare Stock Report

PRO

Why Is It Moving?™:Alvotech shares are trading lower after the company reported worse-than-exp...

Earnings: Q3 2026 Earnings were released on Wed Nov 11th, after the market close

Conference Call: Today's conference call started over 16 hours ago

Click to view the webcast

PRO

Why Is It Moving?™:Alvotech shares are trading lower after the company reported worse-than-exp...

Earnings: Q3 2026 Earnings were released on Wed Nov 11th, after the market close

Conference Call: Today's conference call started over 16 hours ago

Click to view the webcast

Alvotech (ALVO) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Alvotech (ALVO) stock.

Analyst Consensus — 7 Analysts

7Buy

# Analysts7

Latest Upgrades and Downgrades for Alvotech Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Jefferies	Dennis Ding	Initiate	Buy	$9
—	Barclays	Glen Santangelo	Upgrade	Underweight→Overweight	$4→$8
—	B of A Securities	Jason Gerberry	Initiate	Buy	$7
—	Evercore ISI Group	Umer Raffat	Initiate	Outperform	—
—	UBS	Ashwani Verma	PT Cut	Buy	$10→$6
—	Barclays	Glen Santangelo	PT Cut	Underweight	$5→$4
—	Barclays	Glen Santangelo	Initiate	Underweight	$5
—	UBS	Ashwani Verma	PT Cut	Buy	$13→$10
—	Deutsche Bank	Niall Alexander	Downgrade	Buy→Hold	$14→$8
—	Morgan Stanley	Thibault Boutherin	Upgrade	Equal-Weight→Overweight	$14
—	Deutsche Bank	Niall Alexander	Upgrade	Hold→Buy	$14
—	UBS	—	PT Cut	Buy	$16→$14
—	UBS	—	Initiate	Buy	$18
—	Barclays	Balaji Prasad	PT Cut	Overweight	$22→$18
—	Barclays	Balaji Prasad	PT Raise	Overweight	$20→$22
—	Barclays	Balaji Prasad	PT Raise	Overweight	$17→$20
—	Barclays	Balaji Prasad	Upgrade	Equal-Weight→Overweight	$10→$17

Alvotech

Alvotech (ALVO) Stock Price Target 2026

Latest Upgrades and Downgrades for Alvotech Stock

Alvotech (ALVO) Stock Price Target 2026

Latest Upgrades and Downgrades for Alvotech Stock

Analyst Ratings News

PRO
Jefferies Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $9

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

PRO
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

PRO
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

PRO
Evercore ISI Group Initiates Coverage On Alvotech with Outperform Rating

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Jefferies Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $9

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

PRO
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

PRO
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

PRO
Evercore ISI Group Initiates Coverage On Alvotech with Outperform Rating

Alvotech

Alvotech (ALVO) Stock Price Target 2026

Latest Upgrades and Downgrades for Alvotech Stock

Alvotech (ALVO) Stock Price Target 2026

Latest Upgrades and Downgrades for Alvotech Stock

Analyst Ratings News

PROJefferies Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $9

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

PROBarclays Upgrades Alvotech to Overweight, Raises Price Target to $8

PROB of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

PROEvercore ISI Group Initiates Coverage On Alvotech with Outperform Rating

People Also Watch

People Also Watch

Analyst Ratings News

PROJefferies Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $9

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

PROBarclays Upgrades Alvotech to Overweight, Raises Price Target to $8

PROB of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

PROEvercore ISI Group Initiates Coverage On Alvotech with Outperform Rating

PRO
Jefferies Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $9

PRO
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

PRO
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

PRO
Evercore ISI Group Initiates Coverage On Alvotech with Outperform Rating

PRO
Jefferies Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $9

PRO
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

PRO
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

PRO
Evercore ISI Group Initiates Coverage On Alvotech with Outperform Rating